Showing results (1801-1810 of 2,127) with videos related to

Sort By:
Pageof 213
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 22, 2025
T1rho imaging of head and neck cancer: its association with pathological and immunohistochemical biomarkers in nasopharyngeal carcinomaQi Yong H Ai, Amy Bw Chan, Angela Z Chan, et al.
Open Biology|March 1, 2013
Yeast-based automated high-throughput screens to identify anti-parasitic lead compoundsElizabeth Bilsland, Andrew Sparkes, Kevin Williams, et al.
European Radiology|November 26, 2020
Convolutional neural network for discriminating nasopharyngeal carcinoma and benign hyperplasia on MRILun M Wong, Ann D King, Qi Yong H Ai, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 20, 2022
Prognostic value of cervical nodal necrosis on staging imaging of nasopharyngeal carcinoma in era of intensity-modulated radiotherapy: a systematic review and meta-analysisQi-Yong H Ai, Kuo Feng Hung, Tiffany Y So, et al.
Preventive Veterinary Medicine|April 15, 2018
Detection of influenza A virus from agricultural fair environment: Air and surfacesSarah E Lauterbach, Courtney M Wright, Michele M Zentkovich, et al.
Molecular Cell|October 1, 2022
Chromatin jets define the properties of cohesin-driven in vivo loop extrusionYa Guo, Ediem Al-Jibury, Rosalba Garcia-Millan, et al.
Neuro-Oncology|December 15, 2007
Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma modelGwendalyn D King, A K M Ghulam Muhammad, James F Curtin, et al.
Oral Oncology|January 9, 2019
Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynxQi-Yong Ai, Ann D King, Darren M C Poon, et al.
AJNR. American Journal of Neuroradiology|January 12, 2013
T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinomaA D King, C K Keung, K-H Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 20, 2008
Flt3L in combination with HSV1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficitsGwendalyn D King, Kurt M Kroeger, Catherine J Bresee, et al.
Pageof 213